Shigeru Sumitomo

tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan.

Part of Growth Initiative, Inc., GI Equity Partners KK is a Japanese company that provides financial services and consulting. The company is based in Tokyo, Japan.

Part of Growth Initiative, Inc., Realfleet Co., Ltd. distributes electrical and audio products. The company is based in Tokyo, Japan. Realfleet Co. was acquired by GI Equity Partners KK from Francfranc Corp. on December 10, 2010.

Curations, Inc. operates as a business co-creating company that curates professional human resources, latest information and technology, startups and others. The company was founded in July 2013 and is headquartered in Tokyo, Japan.